These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 323867)

  • 1. Mechanisms for the development of bone metastases and hypercalcaemia in patients with breast cancer.
    Powles TJ
    Proc R Soc Med; 1977 Mar; 70(3):199-201. PubMed ID: 323867
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium metabolism in breast cancer.
    Coombes RC; Powles TJ; Joplin DG
    Proc R Soc Med; 1977 Mar; 70(3):195-9. PubMed ID: 870901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
    Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercalcaemia and breast cancer--an increased humoral component in patients with liver metastases.
    Coleman RE; Fogelman I; Rubens RD
    Eur J Surg Oncol; 1988 Oct; 14(5):423-8. PubMed ID: 2846366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy.
    Bundred NJ; Walls J; Ratcliffe WA
    Ann R Coll Surg Engl; 1996 Jul; 78(4):354-8. PubMed ID: 8712650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
    Clines GA; Guise TA
    Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin.
    Powles TJ; Dowsett M; Easty GC; Easty DM; Neville AM
    Lancet; 1976 Mar; 1(7960):608-10. PubMed ID: 55892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant neoplasms and calcium metabolism (a review of the literature)].
    Kashulina AP; Tereshchenko IP
    Patol Fiziol Eksp Ter; 1973; 17(5):84-8. PubMed ID: 4789470
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases.
    Kimura S; Adchi I; Yamaguchi K; Suzuki M; Shimada A; Sato Y; Nagaoka K; Abe K
    Jpn J Cancer Res; 1985 Apr; 76(4):308-14. PubMed ID: 2989061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Dickkopf-1 expression in breast cancer bone metastases.
    Voorzanger-Rousselot N; Goehrig D; Journe F; Doriath V; Body JJ; Clézardin P; Garnero P
    Br J Cancer; 2007 Oct; 97(7):964-70. PubMed ID: 17876334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoblasts suppress high bone turnover caused by osteolytic breast cancer in-vitro.
    Krawetz R; Wu YE; Rancourt DE; Matyas J
    Exp Cell Res; 2009 Aug; 315(14):2333-42. PubMed ID: 19433087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanisms of human tumour-induced osteolysis and hypercalcaemia.
    Dowsett M
    Invest Cell Pathol; 1978; 1(2):159-70. PubMed ID: 401332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
    Sasaki A; Boyce BF; Story B; Wright KR; Chapman M; Boyce R; Mundy GR; Yoneda T
    Cancer Res; 1995 Aug; 55(16):3551-7. PubMed ID: 7627963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of osteotropism on both sides of the breast cancer-bone interaction.
    Moreau J; Anderson KM; Mauney JR; Kaplan D; Rosenblatt M
    Ann N Y Acad Sci; 2007 Nov; 1117():328-44. PubMed ID: 17584985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.
    Kanakis I; Kousidou OCh; Karamanos NK
    In Vivo; 2005; 19(1):311-8. PubMed ID: 15796191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioimmunologic determination of plasma parathormone in hypercalcemia caused by cancer with osseous metastases].
    Lemaire V; Gueris J; Cassou M; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1977 Dec; 44(12):709-13. PubMed ID: 609875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
    Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM
    Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of prostaglandins for tumor growth and tumor symptoms].
    Peskar BM
    Med Klin; 1981 Jan; 76(1):11-4. PubMed ID: 7019649
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial: Prostaglandins, hypercalcemia and cancer.
    Tashjian AH
    N Engl J Med; 1975 Dec; 293(25):1317-8. PubMed ID: 1186828
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of inhibitors of prostaglandin synthesis in patients with breast cancer.
    Powles TJ; Dady PJ; Williams J; Easty GC; Coombes RC
    Adv Prostaglandin Thromboxane Res; 1980; 6():511-6. PubMed ID: 6992539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.